Clenbuterol hydrochloride/Nadolol

盐酸克仑特罗/纳多洛尔

Report date: 2024/07/27 20:00:03

Base Information

Drug NameClenbuterol hydrochloride/Nadolol
Drug Alias NameCST-103/CST-107
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonistsBeta adrenergic receptors inverse agonists
TargetsBeta-2 adrenergic receptorBeta adrenergic receptors
Therapy Area/IndicationsGait Disorders, Neurologic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCuraSen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCuraSen Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsGait Disorders, Neurologic

Other Information

ATC CodeN/A
Related LinksN/A